Global Musculoskeletal Market Size is Expected To Hold a Significant Share By 2033 | CAGR of 6.2%
Category: HealthcareGlobal Musculoskeletal Market Size is Expected To Hold a Significant Share By 2033
According to a research report published by Spherical Insights & Consulting, the Global Musculoskeletal Market Size is Expected to Hold a Significant Share by 2033, at a Compound Annual Growth Rate (CAGR) of 6.2% during the projected period.
Get more details on this report -
Browse key industry insights spread across 213 pages with 110 Market data tables and figures & charts from the report on the "Global Musculoskeletal Market Size, Share, and COVID-19 Impact Analysis, By Type (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others), By Type of Molecules (Biologics, Small Molecules), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/musculoskeletal-market
Musculoskeletal disorders are injuries or illnesses affecting the human musculoskeletal system. The injured or impacted areas are the muscles, ligaments, nerves, tendons, spinal discs, and cartilage. The most common musculoskeletal disorders are rheumatoid arthritis, osteoporosis, gout, osteoarthritis, and back discomfort. Musculoskeletal pain results from normal activities' wear and tear on muscle tissue. WHO studies estimated that 1.71 billion persons worldwide are afflicted with musculoskeletal ailments. The most modern techniques—such as biologics, small molecules, stem cell research, and others help to increase the precision of medication and therapy. Techniques such as organ-on-a-chip, lab-on-a-chip, gene therapy, and orthobiologics have enhanced treatment options for musculoskeletal issues. In addition, treatments such as bone grafting help to mend fractured bones. Thus, it is expected that significant research and development as well as improved care offerings will contribute to market expansion. However, the high cost of care promotes unnecessary MSD care, which limits root-cause treatment.
The osteoarthritis segment is expected to hold the largest share of the musculoskeletal market during the anticipation timeframe.
Based on the type, the musculoskeletal market is categorized into rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, and others. Among these, the osteoarthritis segment is expected to hold the largest share of the musculoskeletal market during the anticipation timeframe. Osteoarthritis is a common chronic joint disease that impacts millions of individuals globally. It mostly affects the elderly, whose numbers are rising due to global aging trends, and is a major contributor to disability.
The biologics segment is expected to grow at the fastest CAGR during the anticipation timeframe.
Based on the type of molecules, the musculoskeletal market is categorized into biologics, and small molecules. Among these, the biologics segment is expected to grow at the fastest CAGR during the anticipation timeframe. Because of their complicated structure, biologics are difficult to detect and classify. Biologics are long-lasting and effective for treating psoriatic, rheumatoid, and other inflammatory arthritis patients. Additionally, biologics products are widely used in biopharmaceuticals for research and drug development, which helps to sustain the market's growth.
North America is projected to hold the largest share of the musculoskeletal market over the anticipation timeframe.
Get more details on this report -
North America is projected to hold the largest share of the musculoskeletal market over the anticipation timeframe. The market in the area has potential due to the rising number of MSD cases brought on by obesity and unhealthy lifestyles, increased awareness, and better treatment choices. Overexertion injuries resulting from lifting, pushing, dragging, holding, carrying, or tossing an object cost business $13.4 billion annually, according to Liberty Mutual, the largest workers' compensation insurance provider in the country. Because these disorders are becoming more common, there is a growing market for musculoskeletal diseases.
Asia Pacific is expected to grow at the fastest CAGR growth of the musculoskeletal market during the anticipation timeframe. Conventional drugs and therapies like as acupuncture support the MSD market in countries like China, India, and Japan. The primary drivers of the sector are the aging of the global population, improvements in medical technology, and more public awareness. But problems like outrageous costs and regulatory barriers must be overcome in order to provide greater access and improved treatment outcomes.
Major vendors in the global musculoskeletal market are Zimmer Biomet Holdings, Inc., Stryker Corporation, Medtronic, Sanofi S.A, Bristol-Myers Squibb, Eli Lilly And Company, Mitsubishi Tanabe Pharma Corporation, EverEx, Horizon Therapeutics plc, Procter & Gamble, Eisai Co. Ltd, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In July 2024, Stryker, a US-based medical device manufacturer, announced that it has effectively purchased Artelon, a soft tissue fixation company, to grow its surgical market share. The acquisition is expected to be valued at $3.4 billion.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global musculoskeletal market based on the below-mentioned segments:
Global Musculoskeletal Market, By Type
- Rheumatoid Arthritis
- Osteoarthritis
- Osteoporosis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Fibromyalgia
- Others
Global Musculoskeletal Market, By Type of Molecule
- Biologics
- Small Molecules
Global Musculoskeletal Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?